PreClinical CRO dedicated to your NonClinical projects
NEWS
Syncrosome at the 7th Microdialysis Symposium 2013 The Central Nervous System department is involved in Blood Brain barrier passage experiments since 10 years now. CSF sampling and Microdialysis are 2 important tools used to evaluate the kinetics of Candidate Compounds but also their action on the Neurotransmitters |
Syncrosome at the 2013 BioChicago Congress Richard Mitry, CEO of Syncrosome, attended the Biochicago Congress last month in United-States. |
Meet Syncrosome during Biotrinity congress As you know SYNCROSOME is a Preclinical Drug Evaluation Company specialised in human health. Since 2000, Syncrosome is mainly focused on in vivo efficacy studies dedicated to discovery and preclinical stage with more than 25 animals models, to provide you the right data to make the right decision. |
Animal models of Inflammatory Bowel Disease (IBD)? Inflammatory Bowel Disease (IBD) is a generic term that covers a range of disease including Ulcerative Colitis (UC) and Crohn's Disease (CD) for which there is still no cure. |
R&D PROJECTS:
Members of EUROBIOMED, the competitiveness pole for health in PACA region
Collaboration with Institut Jean Roche - Institut federatif de recherche 11
« Etude des interactions cellulaires dans le tissu endocrinien, le système nerveux et le tissu epithelial »
Project : NEUROCIDE
« Les neurones détecteurs de PH : de nouveaux acteurs dans les lésions de la moelle épinière. »
Project : RAPSODI
« Pre-clinical studies of a PSA-based human vaccine candidate targeting visceral, cutaneous and mucocutaneous leishmaniasis and development of the associated procedures for further clinical trials. »
Project : ADIABAOX
« Nouvelles sulfonylurées multifonctionnelles pour le traitement du diabète de type 2 »